Skip to main content
Fig. 2 | Alzheimer's Research & Therapy

Fig. 2

From: Longitudinal measurement of serum neurofilament light in presymptomatic familial Alzheimer’s disease

Fig. 2

Serum NfL against AYO. a (In red) measured serum NfL concentration against AYO, for the 27 mutation carriers who have already developed symptoms (either before or during the study). Those measurements that belong to the same individual are connected by a line. No jitter has been applied. The black broken line represents the mean serum NfL concentration for non-carriers, with dotted lines for ± 1.96 SD, calculated on the log scale and back transformed. By showing ± 1.96 SD, we are indicating a reference range within which 95% of the observed values are expected to lie. b Geometric mean NfL modelled against AYO, for someone of average age (40.9 years) and sex (half male/female). The black broken line represents the geometric mean serum NfL concentration for non-carriers. Dotted lines indicate 95% confidence intervals (i.e. on repeated random sampling, 95% of CIs calculated in this way will include the true population geometric mean). AYO actual years to/from symptom onset. The geometric mean is the exponential of a mean calculated on the log scale

Back to article page
\